Table 1

Impact of the NAFLD pathway on hepatitis B and C virus testing in primary care

HBV	Pre-NAFLD pathway	Post-NAFLD pathway	P value	HCV	Pre-NAFLD pathway	Post-NAFLD pathway	P value
Total number of HBsAg tests performed	4586	8005	–	Total number of anti-HCV tests performed	4169	7504	–
Mean number of HBsAg tests per month	173	295	<0.001	Mean number of anti-HCV tests per month	139	250	<0.001
Total number of HBsAg positives	75	68	–	Total number of anti-HCV positives	164	189	–
Positivity rate (%)	1.64	0.85	–	Positivity rate (%)	3.93	2.52	–
New HBsAg positives	47	57	–	New anti-HCV positives	64	76	–
Directly attributable to the NAFLD pathway	n/a	4	–	Directly attributable to the NAFLD pathway	n/a	4	–

HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCV, hepatitis C virus; n/a, not applicable; NAFLD, non-alcoholic fatty liver disease.